| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.009 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.33 | 0.02 |